![]() |
Case Report
1 Cardiovascular Disease Center, Central Hospital of Tujia and Miao Autonomous Prefecture, Hubei University of Medicine, Shiyan, Hubei Province 442000, China
2 Department of Pathology, Central Hospital of Tujia and Miao Autonomous Prefecture, Enshi Clinical College of Wuhan University, Enshi Prefecture, Hubei Province 445000, China
Address correspondence to:
Yuanhong Li
Cardiovascular Disease Center, Central Hospital of Tujia and Miao Autonomous Prefecture, Enshi Prefecture, Hubei Province 445000,
China
Message to Corresponding Author
Article ID: 101317Z01JZ2022
Introduction: Multiple myeloma (MM) is a hematologic disorder that is relatively common in the elderly population. Given the rapid development, limited survival, and poor prognosis of the majority of patients, a definitive, prompt diagnosis is critical for treating individuals with multiple myeloma accompanied with cardiac amyloidosis. The incidence of myocardial amyloidosis with MM, relatively speaking, is low and early clinical manifestations are nonspecific. Atrial thrombi, with low detection, are a hallmark of poor prognosis of patients diagnosed MM with amyloidosis cardiomyopathy.
Case Report: Aiming to serve as useful feedback information for judging the prognosis of target patient, we now analyzed the clinical data of an elderly female with atrial thrombi as the main symptom and impaired cardiac function combined with echocardiography electrocardiography (ECG), laboratory data, cell Congo Red staining and other manifestations to diagnose amyloidosis combined with MM.
Conclusion: The formation of atrial thrombi is closely related to the prognosis of myocardial amyloidosis and in order to identify atrial thrombi early and to intervene early, transesophageal ultrasound should be included as part of routine investigations in patients with myocardial amyloidosis.
Keywords: Atrial thrombi, Echocardiography (ECG), Multiple myeloma (MM), Myocardial amyloidosis
This work was supported by the Effect of Selective Renal Artery Sympathetic Ablation on Ventricular Arrhythmia after Myocardial Infarction (No. WJ2015MA021).
Author ContributionsJingbo Zhao - Substantial contributions to conception and design, Drafting the article, Final approval of the version to be published
Zhu Ni - Acquisition of data, Interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Yinhua Luo - Acquisition of data, Interpretation of data, Drafting the article, Final approval of the version to be published
Rui Huang - Acquisition of data, Interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Ke Su - Acquisition of data, Interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Yuanhong Li - Substantial contributions to conception and design, Revising it critically for important intellectual content, Final approval of the version to be published
Guaranter of SubmissionThe corresponding author is the guarantor of submission.
Source of SupportNone
Consent StatementWritten informed consent was obtained from the patient for publication of this article.
Data AvailabilityAll relevant data are within the paper and its Supporting Information files.
Conflict of InterestAuthors declare no conflict of interest.
Copyright© 2022 Jingbo Zhao et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.